Cost-effectiveness of colorectal cancer surveillance in Hodgkin lymphoma survivors treated with procarbazine and/or infradiaphragmatic radiotherapy

BLM Ykema, A Gini, LS Rigter, MCW Spaander… - … Biomarkers & Prevention, 2022 - AACR
Background: Hodgkin lymphoma survivors treated with infradiaphragmatic radiotherapy
(IRT) and/or procarbazine have an increased risk of developing colorectal cancer. We …
被引用次数：1 相关文章
[PDF] aacrjournals.org

[PDF][PDF] Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy

BLM Ykema, A Gini, LS Rigter, MCW Spaander… - … Biomarkers & Prevention, 2022 - AACR
Background: Hodgkin lymphoma survivors treated with infradiaphragmatic radiotherapy
(IRT) and/or procarbazine have an increased risk of developing colorectal cancer. We …

Cost-effectiveness of colorectal cancer surveillance in Hodgkin lymphoma survivors treated with procarbazine and/or infradiaphragmatic radiotherapy.

BL Ykema, A Gini, LS Rigter, MC Spaander… - … & Prevention: a …, 2022 - europepmc.org
Background Hodgkin lymphoma (HL) survivors (HLS) treated with infradiaphragmatic
radiotherapy (IRT) and/or procarbazine have an increased risk of developing colorectal …
[PDF] eur.nl

[PDF][PDF] Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy

BLM Ykema, A Gini, LS Rigter… - Cancer Epidemiol …, 2022 - pure.eur.nl
Background: Hodgkin lymphoma survivors treated with infradiaphragmatic radiotherapy
(IRT) and/or procarbazine have an increased risk of developing colorectal cancer. We …

Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy

BLM Ykema, A Gini, LS Rigter… - … & prevention: a …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Hodgkin lymphoma survivors treated with infradiaphragmatic radiotherapy (IRT)
and/or procarbazine have an increased risk of developing colorectal cancer. We …
[PDF] ru.nl

[PDF][PDF] Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy

BLM Ykema, A Gini, LS Rigter, MC Spaander… - 2022 - repository.ubn.ru.nl
Background: Hodgkin lymphoma survivors treated with infradiaphragmatic radiotherapy
(IRT) and/or procarbazine have an increased risk of developing colorectal cancer. We …
[HTML] nih.gov

[HTML][HTML] Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy

BLM Ykema, A Gini, LS Rigter… - Cancer Epidemiology …, 2022 - ncbi.nlm.nih.gov
Background: Hodgkin lymphoma survivors treated with infradiaphragmatic radiotherapy
(IRT) and/or procarbazine have an increased risk of developing colorectal cancer. We …
[PDF] universiteitleiden.nl

[PDF][PDF] Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy

BLM Ykema, A Gini, LS Rigter… - Cancer …, 2022 - scholarlypublications …
Background: Hodgkin lymphoma survivors treated with infradiaphragmatic radiotherapy
(IRT) and/or procarbazine have an increased risk of developing colorectal cancer. We …

Cost-effectiveness of colorectal cancer surveillance in Hodgkin lymphoma survivors treated with procarbazine and/or infradiaphragmatic radiotherapy

BLM Ykema, A Gini, LS Rigter… - Cancer …, 2022 - scholarlypublications …
Background: Hodgkin lymphoma survivors treated with infradiaphragmatic radiotherapy
(IRT) and/or procarbazine have an increased risk of developing colorectal cancer. We …